Corruption: Drug makers turning cheap generic drugs into ‘new’ expensive pills

‘When pharmaceuticals go off-patent, the market for generics opens up and prices typically drop – often by a lot. But drug companies have reportedly developed a new scheme to jack prices back up, that involves repackaging multiple generic drugs into one single “new” drug, which is then sold at an outrageous premium.
One example of this is the drug “Treximet,” manufactured by Pernix Therapeutics Holdings Inc. Treximet is made up of two drugs – sumatriptan and naproxen – that are both sold generically for pennies on the dollar. But in the form of Treximet, the combined therapeutic runs upwards of $750 for nine pills, an extortionate price considering the ingredients.’
Read more: Corruption: Drug makers turning cheap generic drugs into ‘new’ expensive pills